Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis: A prospective study

Respiration

Volumn 71, Issue 4, 2004, Pages 360-366

  Horre R ^a,b   Schaal, K P ^a   Siekmeier, R ^a,b   Sterzik, B ^b   De Hoog, G S ^d   Schnitzler, N ^b,c  

^a UNIVERSITY OF BONN   (Germany)

^b Fed Inst Drugs and Med Devices   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d Centraalbureau V S ^*  (Netherlands)

Author keywords

Black yeasts; Cystic fibrosis; Exophiala dermatitidis; Sputum

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYSTIC FIBROSIS; EXOPHIALA; EXOPHIALA DERMATITIDIS; FEMALE; FUNGAL CELL CULTURE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SAMPLING; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EXOPHIALA; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; SPUTUM;

EID: 4444353140     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079640     Document Type: Article

References (26)

1. Haase G, Skopnik H, Kusenbach G: Exophiala dermatitidis infection in cystic fibrosis. Lancet 1990;336:188-189.
2. Kusenbach G, Skopnik H, Haase G, Friedrichs F, Dolmen H: Exophiala dermatitidis pneumonia in cystic fibrosis. Eur J Pediatr 1992;151:344-346.
3. De Hoog GS, Haase G: Nutritional physiology and selective isolation of Exophiala dermatitidis. Antonie Van Leeuwenhoek 1993;64:17-26.
4. De Hoog GS, Guarro J, Gené J, Figueras MJ (eds): Atlas of Clinical Fungi, ed 2. Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000, p 51.
5. Haase G, Skopnik H, Groten T, Kusenbach G, Posselt HG: Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 1991;34:373-376.
6. Hughes WT, Kim HK: Mycoflora in cystic fibrosis: Some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathol Mycol Appl 1973;50:261-269.
7. Blaschke-Hellmessen R, Lauterbach I, Paul KD, Tintelnot K, Weissbach G: Detection of Exophiala dermatitidis (Kano) De Hoog 1977 in septicaemia of a child with acute lymphatic leukaemia and from patients with cystic fibrosis. Mycoses 1994;37(suppl 1):89-96.
8. Blaschke-Hellmessen R, Paul KD, Ulbrich K, Jentsch Y: Exophiala dermatitidis bei Mukoviszidose. Diagnostik, klinische Bedeutung und Therapie (poster 26, abstract). 29th Annual Meeting of the German-speaking Mycological Society (DG-Myk), Dresden, Sept 1997, p 108.
9. Horré R, Schröteler A, Marklein G, Breuer G, Siekmeier R, Sterzik B, Schnitzler N, de Hoog GS, Schaal KP: Langzeitkulturen bei Patienten mit zystischer Fibrose zum Nachweis der 'schwarzen Hefe' Exophiala dermatitidis (abstract E2). Pneumologie 2002;56:748.
10. Mouton JW, Brimicombe R, Weel J, Meis JFG, De Hoog GS: Exophiala dermatitidis in patients with cystic fibrosis: A survey in the Netherlands. Topic Index - 20th EWGCF, Brussels, June 1995 European Cystic Fibrosis Society (ECFS). http://www.ecfsoc.org.
11. Rath PM, Muller KD, Dermoumi H, Ansorg R: A comparison of methods of phenotypic and genotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis. J Med Microbiol 1997;46:757-762.
12. Schmalreck AF, Tränkle P, Vanca E, Blaschke-Hellmessen R: Differentiation and characterization of Candida albicans, Exophiala dermatitidis and Prototheca spp by Fourier-transform infrared Spectroscopy (FT-IR) in comparison with conventional methods. Mycoses 1998;41(suppl 1):71-77.
13. Diemert D, Kunimoto D, Sand C, Rennie R: Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand J Infect Dis 2001;33:777-779.
14. Kabel PJ, Illy KE, Holl RA, Buiting AG, Wintermans RG: Nosocomial intravascular infection with Exophiala dermatitidis. Lancet 1994;344:1167-1168.
15. Woollons A, Darley CR, Paudian S, Arnstein P, Blackee J, Paul J: Phaeohyphomycosis caused by Exophiala dermatitidis following intraarticular steroid injection. Br J Dermatol 1996;135:475-477.
16. Anonymous: FDA issues warning on injected drugs. ProMED-mail post, a program of the Int Soc for Infect Dis AP Online (cited16 November 2002); available from the Internet: http:// www.promedmail.org.
17. Haase G, Conrad C, Kentrup H, Schnitzler N: Nachweis von Exophiala dermatitidis-spezifischen Antikörpern bei Patienten mit Cystischer Fibrose (poster 22, abstract). 31st Annual Meeting of the German-speaking Mycological Society (DG-Myk), Aachen, Sept 1997, p 93.
18. Bakare N, Rickerts V, Bargon J, Just-Nübling G: Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003;46:19-23.
19. Kerr JR, Taylor GW, Rutman A, Hoiby N, Cole PJ, Wilson R: Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J Clin Pathol 1999;52:385-387.
20. Blaschke-Hellmessen R, Paul KD, Jentsch Y: Klinische Bedeutung, Nachweis und Umweltverhalten der 'Schwarzen Hefe' Exophiala dermatitidis (poster 224, abstract 213). 48th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), Bonn, Oct 1996.
21. Matos T, De Hoog GS, De Boer AG, De Crom I, Haase G: High prevalence of the neurotropic Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 2002;45:373-377.
22. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, Mastella G, Navarro J, Strandvik B, McKenzie S: European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001;31:1-12.
23. Horré R, De Hoog GS: Primary cerebral infections by melanized fungi: A review. Stud Mycol 1999;45:176-194.
24. Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP: Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000;19:53-56.
25. Schell WA: New aspects of emerging fungal pathogens. A multifaceted challenge. Clin Lab Med 1995;15:365-387.
26. Perfect JR, Schell WA: The new fungal opportunists are coming. Clin Infect Dis 1996;22(suppl 2):S112-S118.